inotuzumab ozogamicin (besponsa) Report issue

Biologics mAb ADC Orphan Drug FDA Approved FDA First in Class
Back

Drug Pricing Summary

VA Big4

$738.6860

VA FSS

$949.4840

AUS PBS

$10163.5938

Drug Product Pricing

Product $/unit Ctry. List Type
Product (units) Manufacturer
inotuzumab ozogamicin 0.25 mg / 1 mL (1 mL INJECTION) $738.6860 VA Big4
  • Besponsa (20)
  • Pfizer, Inc.
    inotuzumab ozogamicin 0.25 mg / 1 mL (1 mL INJECTION) $949.4840 VA FSS
  • Besponsa (20)
  • Pfizer, Inc.
    inotuzumab ozogamicin 1 mg (INJECTION) $10163.5938 AUS PBS generic
  • Besponsa (1)
  • Pfizer Australia Pty Ltd

    Note: This drug pricing data is preliminary, incomplete, and may contain errors.

    Feedback

    Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

    Report issue